Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation

Kidney International

Volumn 82, Issue 4, 2012, Pages 436-444

  Lu, Jingjun ^a   Wang, Xianwei ^b   Wang, Wenze ^b   Muniyappa, Harish ^b   Deshmukh, Abhishek ^b   Hu, Changping ^b   Das, Kumuda ^b   Mehta, Jawahar L ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

inflammation; LOX 1; myocardial infarction; renal function

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART WEIGHT; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KNOCKOUT MOUSE; LIPID PEROXIDATION; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; WILD TYPE;

EID: 84864555131     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.186     Document Type: Article

References (38)

1. Ronco C, Haapio M, House AA et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
2. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 2004; 110: 1514-1517.
3. Martínez-Santos P, Vilacosta I. Cardiorenal syndrome: an unsolved clinical problem. Int J Nephrol 2011: 913029 (E-pub ahead of print 29 May 2011).
4. Gobal F, Deshmukh A, Shah S et al. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating. J Am Coll Cardiol 2011; 57: 2303-2308.
5. van Kimmenade RR, Pinto Y, Januzzi Jr JL. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'? Eur Heart J 2007; 28: 2960-2961.
6. Jose P, Skali H, Anavekar N et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006; 17: 2886-2891.
7. Goldberg A, Hammerman H, Petcherski S et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005; 150: 330-337.
8. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 2006; 1: 8-18.
9. Tokuyama H, Kelly DJ, Zhang Y et al. Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia. Nephron Physiol 2007; 106: 54-62.
10. Li D, Williams V, Liu L et al. LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol 2002; 283: H1795-H1801.
11. Li D, Williams V, Liu L et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1048-1055.
12. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-508.
13. Hasslacher J, Bijuklic K, Bertocchi C et al. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study. Crit Care 2011; 15: R166.
14. Li D, Saldeen T, Romeo F et al. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 2000; 102: 1970-1976.
15. Cominacini L, Pasini AF, Garbin U et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000; 275: 12633-12638.
16. Ishino S, Mukai T, Kuge Y et al. Targeting of lectin like oxidized lowdensity lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med 2008; 49: 1677-1685.
17. Hu C, Dandapat A, Chen J et al. LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. Cardiovasc Res 2007; 76: 292-302.
18. Lu J, Wang X, Wang W et al. LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Ther 2012; 19: 522-531.
19. Fujiu K, Manabe I, Nagai R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 2011; 121: 3425-3441.
20. Hu C, Chen J, Dandapat A et al. LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J Mol Cell Cardiol 2008; 44: 76-83.
21. Anilkumar N, Weber R, Zhang M et al. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling response to agonist stimulation. Arterioscler Thromb Vasc Biol 2008; 28: 1347-1354.
22. Ahmed A, Fujisawa T, Nui XL et al. Angiopoietin-2 confers atheroprotection in apoE-/-mice by inhibiting LDL oxidation via nitric oxide. Circ Res 2009; 104: 1333-1336.
23. Cominacini L, Pasini AF, Garbin U et al. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol 2003; 41: 499-507.
24. Lu J, Mitra S, Wang X et al. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal 2011; 15: 2301-2333.
25. Mehta JL. Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis? J Am Coll Cardiol 2006; 48: 980-982.
26. Hu C, Kang BY, Megyesi J et al. Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int 2009; 76: 521-527.
27. Honjo M, Nakamura K, Yamashiro K et al. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci USA 2003; 100: 1274-1279.
28. Doerries C, Grote K, Hilfiker-Kleiner D et al. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007; 100: 894-903.
29. Chen K, Chen J, Li D et al. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 2004; 44: 655-665, 661.
30. Chen K, Chen J, Liu Y et al. Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids. Hypertension 2005; 46: 622-627.
31. Chen K, Li D, Zhang X et al. Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol 2004; 44: 682-687.
32. Hu C, Dandapat A, Sun L et al. Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem 2008; 283: 10226-10231.
33. Kelly KJ, Burford JL, Dominguez JH. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 2009; 297: F923-F931.
34. Dominguez JH, Mehta JL, Li D et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am J Physiol Renal Physiol 2008; 294: F110-F119.
35. Mehta JL, Sanada N, Hu CP et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007; 100: 1634-1642.
36. Qi Z, Whitt I, Mehta A et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 2004; 286: F590-F596.
37. Jia Z, Aoyagi T, Yang T. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 2010; 55: 539-546.
38. Hu C, Dandapat A, Sun L et al. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension 2008; 52: 556-562.